Cibc World Market Inc. Immunity Bio, Inc. Transaction History
Cibc World Market Inc.
- $47.5 Billion
- Q2 2025
A detailed history of Cibc World Market Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 16,700 shares of IBRX stock, worth $39,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,700
Previous 12,700
31.5%
Holding current value
$39,412
Previous $38,000
15.79%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
281Shares Held
121MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$51.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$27 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$20.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$18.3 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$18.2 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $945M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...